Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
International Journal of Cancer|September 17, 1996
Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniquesA Devys, P Thedrez, E Gautherot, et al.International Journal of Cancer|April 1, 1992
Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: uptake, retention kinetics and dosimetric evaluationM Bardiès, P Thedrez, J F Gestin, et al.EJNMMI Research|August 18, 2020
177Lu radiolabeling and preclinical theranostic study of 1C1m-Fc: an anti-TEM-1 scFv-Fc fusion protein in soft tissue sarcomaJ A Delage, A Faivre-Chauvet, J K Fierle, et al.Nuclear Medicine and Biology|April 25, 2014
Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapyS Gouard, A Pallardy, J Gaschet, et al.Nuclear Medicine and Biology|February 4, 2014
Influence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibodyA Rauscher, M Frindel, C Maurel, et al.The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|March 21, 2007
Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapyE Jestin, M Mougin-Degraef, A Faivre-Chauvet, et al.Nuclear Medicine and Biology|August 1, 1993
Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic methodJ F Gestin, A Faivre-Chauvet, R C Mease, et al.Nuclear Medicine and Biology|August 1, 1993
Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude miceA Faivre-Chauvet, J F Gestin, R C Mease, et al.Nuclear Medicine Communications|September 1, 1996
Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibodyA Faivre-Chauvet, R C Mease, A Chetanneau, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 24, 2001
Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studiesJ F Gestin, A Loussouarn, M Bardiès, et al.Pageof 3